Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Baylor Genetics | RCV000779150 | SCV004203126 | likely pathogenic | Alpha-1-antitrypsin deficiency | 2023-06-24 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000779150 | SCV001226863 | pathogenic | Alpha-1-antitrypsin deficiency | 2020-12-25 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has been observed as heterozygous in an individual with cough, dyspnea, wheeze, and asthma (PMID: 25425243). ClinVar contains an entry for this variant (Variation ID: 632223). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Thr204Serfs*11) in the SERPINA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SERPINA1 are known to be pathogenic (PMID: 25425243). |